AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 228 filers reported holding AXSOME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.64 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,322,481 | -35.2% | 18,922 | -33.3% | 0.00% | -100.0% |
| Q2 2023 | $2,040,106 | -50.1% | 28,390 | -57.2% | 0.00% | 0.0% |
| Q1 2023 | $4,087,410 | -31.1% | 66,268 | -13.9% | 0.00% | -50.0% |
| Q4 2022 | $5,936,387 | +80.2% | 76,966 | +4.3% | 0.00% | +100.0% |
| Q3 2022 | $3,294,000 | +790.3% | 73,822 | +662.8% | 0.00% | – |
| Q2 2022 | $370,000 | -7.5% | 9,678 | +0.1% | 0.00% | – |
| Q1 2022 | $400,000 | -30.1% | 9,672 | -36.1% | 0.00% | – |
| Q4 2021 | $572,000 | +606.2% | 15,148 | +513.3% | 0.00% | – |
| Q3 2021 | $81,000 | -62.1% | 2,470 | -22.1% | 0.00% | – |
| Q2 2021 | $214,000 | -49.2% | 3,171 | -57.4% | 0.00% | – |
| Q1 2021 | $421,000 | -78.3% | 7,438 | -68.8% | 0.00% | – |
| Q4 2020 | $1,944,000 | +93.8% | 23,849 | +69.4% | 0.00% | – |
| Q3 2020 | $1,003,000 | -48.6% | 14,082 | -40.6% | 0.00% | -100.0% |
| Q2 2020 | $1,950,000 | -29.5% | 23,701 | -49.6% | 0.00% | 0.0% |
| Q1 2020 | $2,766,000 | -40.1% | 47,022 | +5.2% | 0.00% | 0.0% |
| Q4 2019 | $4,619,000 | +323.8% | 44,681 | -17.1% | 0.00% | – |
| Q3 2019 | $1,090,000 | -11.0% | 53,907 | +13.4% | 0.00% | – |
| Q2 2019 | $1,225,000 | +1125.0% | 47,550 | +576.9% | 0.00% | – |
| Q1 2019 | $100,000 | +284.6% | 7,025 | -23.6% | 0.00% | – |
| Q4 2018 | $26,000 | -33.3% | 9,200 | -17.9% | 0.00% | – |
| Q3 2018 | $39,000 | -13.3% | 11,200 | -21.1% | 0.00% | – |
| Q2 2018 | $45,000 | +350.0% | 14,200 | +238.1% | 0.00% | – |
| Q1 2018 | $10,000 | -58.3% | 4,200 | 0.0% | 0.00% | – |
| Q4 2017 | $24,000 | +118.2% | 4,200 | +110.0% | 0.00% | – |
| Q3 2017 | $11,000 | +22.2% | 2,000 | -14.0% | 0.00% | – |
| Q1 2017 | $9,000 | -43.8% | 2,325 | 0.0% | 0.00% | – |
| Q4 2016 | $16,000 | -11.1% | 2,325 | 0.0% | 0.00% | – |
| Q3 2016 | $18,000 | +125.0% | 2,325 | +132.5% | 0.00% | – |
| Q2 2016 | $8,000 | -38.5% | 1,000 | -34.1% | 0.00% | – |
| Q1 2016 | $13,000 | – | 1,517 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,008,508 | $82,980,000 | 48.53% |
| Fairmount Funds Management LLC | 216,098 | $17,781,000 | 7.93% |
| WMS Partners, LLC | 250,000 | $20,570,000 | 4.26% |
| RTW INVESTMENTS, LP | 1,658,316 | $136,446,000 | 3.84% |
| MORGAN JESS S & CO INC | 39,328 | $3,236,000 | 3.51% |
| RA Capital Management | 2,035,132 | $167,451,000 | 3.26% |
| Ghost Tree Capital, LLC | 100,000 | $8,228,000 | 2.17% |
| ACUTA CAPITAL PARTNERS, LLC | 90,000 | $7,405,000 | 2.14% |
| Avidity Partners Management LP | 404,900 | $33,315,000 | 2.14% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 1,085,836 | $89,343,000 | 1.97% |